279 related articles for article (PubMed ID: 12044582)
21. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
Feron O; Dessy C; Desager JP; Balligand JL
Circulation; 2001 Jan; 103(1):113-8. PubMed ID: 11136695
[TBL] [Abstract][Full Text] [Related]
22. Drug Insight: statins and stroke.
Sacco RL; Liao JK
Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):576-84. PubMed ID: 16258569
[TBL] [Abstract][Full Text] [Related]
23. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.
Lefer AM; Scalia R; Lefer DJ
Cardiovasc Res; 2001 Feb; 49(2):281-7. PubMed ID: 11164838
[No Abstract] [Full Text] [Related]
24. Endothelium-dependent effects of statins.
Wolfrum S; Jensen KS; Liao JK
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):729-36. PubMed ID: 12615672
[TBL] [Abstract][Full Text] [Related]
25. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
[TBL] [Abstract][Full Text] [Related]
26. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
Mason RP; Walter MF; Jacob RF
Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
[TBL] [Abstract][Full Text] [Related]
27. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.
Koh KK
Cardiovasc Res; 2000 Sep; 47(4):648-57. PubMed ID: 10974215
[TBL] [Abstract][Full Text] [Related]
28. Statin therapy for coronary heart disease and its effect on stroke.
Switzer JA; Hess DC
Curr Atheroscler Rep; 2006 Jul; 8(4):337-42. PubMed ID: 16822401
[TBL] [Abstract][Full Text] [Related]
29. The effects of HMG-CoA reductase inhibitors on endothelial function.
Tesfamariam B
Am J Cardiovasc Drugs; 2006; 6(2):115-20. PubMed ID: 16555864
[TBL] [Abstract][Full Text] [Related]
30. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
Zhou Q; Liao JK
Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
[TBL] [Abstract][Full Text] [Related]
31. [HMG-CoA reductase inhibitor and risk of stroke].
Endres M; Laufs U
Nervenarzt; 1998 Aug; 69(8):717-21. PubMed ID: 9757426
[TBL] [Abstract][Full Text] [Related]
32. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
33. Rho GTPases, statins, and nitric oxide.
Rikitake Y; Liao JK
Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
[TBL] [Abstract][Full Text] [Related]
34. New insights into the pleiotropic effects of statins for stroke prevention.
Pezzini A; Del Zotto E; Volonghi I; Giossi A; Costa P; Padovani A
Mini Rev Med Chem; 2009 Jun; 9(7):794-804. PubMed ID: 19519504
[TBL] [Abstract][Full Text] [Related]
35. Effects of statins on endothelium and signaling mechanisms.
Endres M; Laufs U
Stroke; 2004 Nov; 35(11 Suppl 1):2708-11. PubMed ID: 15375300
[TBL] [Abstract][Full Text] [Related]
36. Beneficial cardiovascular pleiotropic effects of statins.
Davignon J
Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
[TBL] [Abstract][Full Text] [Related]
37. [Novel actions of HMG-CoA reductase inhibitors(statins)--vascular and cerebral protection through inhibition of small GTPase Rho].
Sawada N; Itoh H; Nakao K
Nihon Rinsho; 2001 Dec; 59(12):2470-5. PubMed ID: 11766357
[TBL] [Abstract][Full Text] [Related]
38. The acute (cerebro)vascular effects of statins.
Prinz V; Endres M
Anesth Analg; 2009 Aug; 109(2):572-84. PubMed ID: 19608834
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium.
Chłopicki S; Gryglewski RJ
Pharmacol Rep; 2005; 57 Suppl():86-96. PubMed ID: 16415489
[TBL] [Abstract][Full Text] [Related]
40. Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?
Vaughan CJ; Delanty N; Basson CT
CNS Drugs; 2001; 15(8):589-96. PubMed ID: 11524031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
